Artelo Biosciences Receives Patent Allowance for Investigational Drug

Artelo Biosciences has been granted a Notice of Allowance from the U.S. Patent and Trademark Office for its leading investigational drug, which is currently undergoing two Phase 2 studies.

17 Aug, 12:52 — 17 Aug, 12:52

Post Share

Sources

Showing 1 of 1 sources

taiwan-newsMostly Factual17d ago

Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies - Taiwan News

Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies Taiwan News

Read full article →

Artelo Biosciences Receives Patent Allowance for Investigational Drug

Sources

Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies - Taiwan News

Related Stories

New Zealand Approves MDMA Prescription for PTSD Treatment

UNICEF Report Reveals 20 Million Children Face Annual Online Sexual Exploitation

Genetically Modified Pig Kidney Sustains Patient for Record Nine Months

Pentagon Temporarily Rescinds Testosterone Screening Guidance for Troops